123 related articles for article (PubMed ID: 12403231)
1. Thrombotic complications during induction chemotherapy of acute childhood lymphoblastic leukemia.
Kankirawatana S; Veerakul G; Sanpakit K; Tanphaichitr VS; Akkabutr P; Suwantol L; Mahasandana C
J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S549-57. PubMed ID: 12403231
[TBL] [Abstract][Full Text] [Related]
2. L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia.
Appel IM; Hop WC; van Kessel-Bakvis C; Stigter R; Pieters R
Thromb Haemost; 2008 Aug; 100(2):330-7. PubMed ID: 18690355
[TBL] [Abstract][Full Text] [Related]
3. Effects of high-dose methotrexate on the hemostatic system in childhood acute lymphoblastic leukemia.
Totan M; Dagdemir A; Ak AR; Albayrak D; Kucukoduk S
Med Pediatr Oncol; 2001 Apr; 36(4):429-33. PubMed ID: 11260565
[TBL] [Abstract][Full Text] [Related]
4. Effects of dose-reduced Medac L-asparaginase on coagulation in trial ALL-BFM 2000.
Attarbaschi A; Mann G; Kronberger M; Witt V; Gadner H; Dworzak M
Klin Padiatr; 2003; 215(6):321-6. PubMed ID: 14677096
[TBL] [Abstract][Full Text] [Related]
5. Alterations in procoagulant, anticoagulant, and fibrinolytic systems before and after start of induction chemotherapy in children with acute lymphoblastic leukemia.
Albayrak M; Gürsel T; Kaya Z; Koçak U
Clin Appl Thromb Hemost; 2013; 19(6):644-51. PubMed ID: 22751908
[TBL] [Abstract][Full Text] [Related]
6. Bleeding and thrombosis in children with acute lymphoblastic leukaemia, treated according to the ALL-BFM-90 protocol.
Sutor AH; Mall V; Thomas KB
Klin Padiatr; 1999; 211(4):201-4. PubMed ID: 10472550
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia.
Rivera GK; Zhou Y; Hancock ML; Gajjar A; Rubnitz J; Ribeiro RC; Sandlund JT; Hudson M; Relling M; Evans WE; Pui CH
Cancer; 2005 Jan; 103(2):368-76. PubMed ID: 15599932
[TBL] [Abstract][Full Text] [Related]
8. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study.
Mitchell LG; Andrew M; Hanna K; Abshire T; Halton J; Anderson R; Cherrick I; Desai S; Mahoney D; McCuster P; Wu J; Dahl G; Chait P; de Veber G; Lee KJ; Mikulis D; Ginsberg J; Way C;
Cancer; 2003 Jan; 97(2):508-16. PubMed ID: 12518376
[TBL] [Abstract][Full Text] [Related]
9. [Thrombosis in children with acute lymphoblastic leukemia treated with the COALL protocol].
Eckhof-Donovan S; Schwamborn D; Körholz D; Michelmann I; von Kries R; Nürnberger W; Göbel U
Klin Padiatr; 1994; 206(4):327-30. PubMed ID: 7967433
[TBL] [Abstract][Full Text] [Related]
10. [Transient dysfibrinogenemia and cerebral thrombosis following remission induction therapy for acute lymphoblastic leukemia].
Kubota T; Okamura T; Hayashi S; Nagafuchi S; Ohtsuka T; Shibuya T; Harada M; Niho Y
Rinsho Ketsueki; 1990 Sep; 31(9):1517-22. PubMed ID: 2246826
[TBL] [Abstract][Full Text] [Related]
11. [Superior sagittal sinus thrombosis following L-asparaginase therapy of acute lymphoblastic leukemia].
Watanabe I; Sakai I; Matsumoto I
Rinsho Ketsueki; 1992 Mar; 33(3):343-8. PubMed ID: 1578639
[TBL] [Abstract][Full Text] [Related]
12. Disseminated intravascular coagulation in acute leukemia at presentation and during induction therapy.
Dixit A; Chatterjee T; Mishra P; Kannan M; Choudhry DR; Mahapatra M; Choudhry VP; Saxena R
Clin Appl Thromb Hemost; 2007 Jul; 13(3):292-8. PubMed ID: 17636191
[TBL] [Abstract][Full Text] [Related]
13. Central venous lines in children with lesser risk acute lymphoblastic leukemia: optimal type and timing of placement.
McLean TW; Fisher CJ; Snively BM; Chauvenet AR
J Clin Oncol; 2005 May; 23(13):3024-9. PubMed ID: 15860859
[TBL] [Abstract][Full Text] [Related]
14. Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study.
Hunault-Berger M; Chevallier P; Delain M; Bulabois CE; Bologna S; Bernard M; Lafon I; Cornillon J; Maakaroun A; Tizon A; Padrazzi B; Ifrah N; Gruel Y;
Haematologica; 2008 Oct; 93(10):1488-94. PubMed ID: 18728028
[TBL] [Abstract][Full Text] [Related]
15. Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: comparison of fracture risk with the General Practice Research Database.
Högler W; Wehl G; van Staa T; Meister B; Klein-Franke A; Kropshofer G
Pediatr Blood Cancer; 2007 Jan; 48(1):21-7. PubMed ID: 16317756
[TBL] [Abstract][Full Text] [Related]
16. [Intensification of chemotherapy in maintenance therapy and in periodic reinduction of remission in high-risk childhood ALL].
Indiano JM; Echaniz I; Humayor J; Delgado A
An Esp Pediatr; 1988 Oct; 29 Suppl 34():94-8. PubMed ID: 3214047
[No Abstract] [Full Text] [Related]
17. Changes in hypercoagulability by asparaginase: a randomized study between two asparaginases.
Appel IM; Hop WC; Pieters R
Blood Coagul Fibrinolysis; 2006 Mar; 17(2):139-46. PubMed ID: 16479196
[TBL] [Abstract][Full Text] [Related]
18. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD
Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia.
Lund B; Åsberg A; Heyman M; Kanerva J; Harila-Saari A; Hasle H; Söderhäll S; Jónsson ÓG; Lydersen S; Schmiegelow K;
Pediatr Blood Cancer; 2011 Apr; 56(4):551-9. PubMed ID: 21298739
[TBL] [Abstract][Full Text] [Related]
20. Roles of protein C, protein S, and antithrombin III in acute leukemia.
Dixit A; Kannan M; Mahapatra M; Choudhry VP; Saxena R
Am J Hematol; 2006 Mar; 81(3):171-4. PubMed ID: 16493609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]